Update on CMV Management In Transplant Patients idse.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from idse.net Daily Mail and Mail on Sunday newspapers.
Seelos Therapeutics, Inc. a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital has selected Seelos’ Phase IIbIII study of SLS-005 to be included in the HEALEY ALS Platform Trial, the first ever platform trial for the treatment of …
– Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital has selected Seelos’ Phase IIbIII study of SLS-005 (trehalose) to be included in the HEALEY ALS Platform Trial, the first ever platform trial for the treatment of amyotrophic lateral sclerosis (ALS or Lou Gehrig’s disease).